Alpha 2.0
Login Register
» Articles » PMID: 32766367

Pancreatic Neuroendocrine Tumor-Induced Hyperammonemic Encephalopathy in the Absence of Hepatic Involvement

Overview
Journal ACG Case Rep J
Specialty Gastroenterology
Date 2020 Aug 9
PMID 32766367
Citations 3
Authors
Ann S Monardo
Akiva J Marcus
Andrew C Berry
Affiliations
Soon will be listed here.
Citing Articles

Hepatic Encephalopathy Without Hyperammonemia in the Setting of Liver Metastases by a Pancreatic Neuroendocrine Tumor.

Toyama N, Tsukamoto R, Kuroda M, Noguchi Y, Sairenji T, Osugi Y Cureus. 2024; 16(10):e71999.

PMID: 39569231 PMC: 11577306. DOI: 10.7759/cureus.71999.

Hyperammonemic Encephalopathy in a Patient with Pancreatic Neuroendocrine Tumor and Portosystemic Shunt.

Zorgdrager M, Cuperus F, de Haas R Diagnostics (Basel). 2023; 13(3).

PMID: 36766677 PMC: 9914007. DOI: 10.3390/diagnostics13030572.

Marked improvement in hyperammonaemic encephalopathy from multimodal treatment of metastatic neuroendocrine tumour.

Davis A, Clarke S, Ayesa S, Chan D BMJ Case Rep. 2021; 14(6).

PMID: 34193447 PMC: 8246280. DOI: 10.1136/bcr-2020-241191.

References
1.
Frederick R . Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y). 2011; 7(4):222-33. PMC: 3127024. View
2.
Willson K, Nott L, Broadbridge V, Price T . Hepatic encephalopathy associated with cancer or anticancer therapy. Gastrointest Cancer Res. 2013; 6(1):11-6. PMC: 3597933. View
3.
Ito T, Igarashi H, Jensen R . Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2013; 26(6):737-53. PMC: 3627221. DOI: 10.1016/j.bpg.2012.12.003. View
4.
McKenna L, Edil B . Update on pancreatic neuroendocrine tumors. Gland Surg. 2014; 3(4):258-75. PMC: 4244504. DOI: 10.3978/j.issn.2227-684X.2014.06.03. View